Medro Asia provides guidance, advise and services related to new drug development programs to industry, academic and educational institutions, health care professionals and authorities. We are a team of passionate, energetic and medically qualified professionals with extensive clinical and industry experience. Our experts and consultants, probably the best in specific therapeutic areas and subject matters, can provide professional and personalized advice and guidance for optimal fast-track clinical development for new products with registration and successful market entry. Medro Asia is a Korean government supported startup with an office and staff located in Seoul with our experts based globally in Asia, Europe and United States. In addition to our operational services like medical writing and MA activities, we support for a wide spectrum of services including development of Clinical Development Plans (CDP), Target Product Profiles (TPP), Proof of Concept (POC) plans, biomarker and health outcome studies, fast-track developments and a wide range of expert reports.